T2 Biosystems (NASDAQ:TTOO) Earns Sell Rating from Analysts at StockNews.com

Analysts at StockNews.com started coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Stock Up 8.0 %

Shares of NASDAQ TTOO opened at $0.14 on Friday. The business has a fifty day moving average price of $0.25 and a two-hundred day moving average price of $1.08. T2 Biosystems has a fifty-two week low of $0.06 and a fifty-two week high of $6.80.

T2 Biosystems Company Profile

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.